S&P Futures
3,810.50-6.25(-0.16%)Dow Futures
31,223.00-13.00(-0.04%)Nasdaq Futures
12,649.25-32.50(-0.26%)
Champions Oncology, Inc. (CSBR)
Chart Events
Performance Outlook
| Previous Close | 12.21 |
| Open | 12.07 |
| Bid | 0.00 x 1800 |
| Ask | 0.00 x 3000 |
| Day's Range | 11.72 - 12.36 |
| 52 Week Range | 4.02 - 13.45 |
| Volume | 36,617 |
| Avg. Volume | 37,084 |
| Market Cap | 157.754M |
| Beta (5Y Monthly) | 1.23 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.13 |
| Earnings Date | Mar 10, 2021 - Mar 15, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13.83 |
- ACCESSWIRE
Champions Oncology Announces Addition to Board of Directors
HACKENSACK, NJ / ACCESSWIRE / February 22, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR) a leading global oncology technology solutions provider transforming drug discovery through innovative pharmacology, biomarker, and data platforms, is pleased to announce the appointment of Rob Brainin to its Board of Directors.
- Simply Wall St.
Can You Imagine How Jubilant Champions Oncology's (NASDAQ:CSBR) Shareholders Feel About Its 220% Share Price Gain?
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
- ACCESSWIRE
Champions Oncology Announces Partnership with Code Ocean to Expand the Functionality of Lumin Bioinformatics
HACKENSACK, NJ / ACCESSWIRE / January 19, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology company that is transforming drug discovery and development through data-driven research strategies, announced today a partnership with Code Ocean to expand the functionality of its SaaS program, Lumin Bioinformatics.
